Cointelegraph Research explains how Eclipse pairs SVM execution with Ethereum settlement and Celestia data availability. What ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the completion of enrollment for ECLIPSE 1, a Phase 3 trial evaluating the safety and efficacy of the combination of tobevibart and elebsiran in ...

SAN FRANCISCO, November 03, 2025--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the completion of enrollment for ECLIPSE 1, a Phase 3 trial evaluating the safety and efficacy ...

Firefly Aerospace Inc. (NASDAQ:FLY) Q2 2025 Earnings Call Transcript September 23, 2025 Operator: Greetings. Welcome to the Firefly Aerospace Second Quarter 2025 Financial Results Conference Call.

The year’s second total lunar eclipse saw Earth’s shadow obscure this weekend’s full moon as the home planet lined up perfectly between the moon and the sun. Watch The Virtual Telescope Project’s ...

Find expert weather insights and travel advice in this essential guide to the 2027 total solar eclipse in Spain, Egypt and North Africa. On Aug. 2, 2027, a total solar eclipse will cast its shadow ...

Our polar cruise departing Iceland to watch the eclipse in Scoresby Sund in Greenland is nearly sold out. The full itinerary details including information on the eclipse experts that will join ...

ECLIPSE registrational program now fully underway, following enrollment of the first patient in ECLIPSE 3 ECLIPSE 3 is designed to compare the combination of tobevibart and elebsiran to bulevirtide in ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in the ECLIPSE 2 Phase 3 clinical trial, which is designed to compare the ...

CEO Marianne De Backer emphasized Vir's progress in advancing its infectious disease and oncology programs. Key milestones include initiating the ECLIPSE Phase III registrational program for hepatitis ...